Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroto Inaba

Showing results (51-60 of 214) with videos related to

Pageof 22
Sort By:
Haematologica|February 13, 2025
Changes in asparaginase exposure and toxicity profiles in obese pediatric acute lymphoblastic leukemia patientsJohn C Panetta, Emily Ashcraft, Sima Jeha, et al.
Pediatric Blood & Cancer|April 24, 2020
Higher plasma asparaginase activity after intramuscular than intravenous Erwinia asparaginaseJohn C Panetta, Yiwei Liu, Hope D Swanson, et al.
Molecular Cancer Therapeutics|May 17, 2008
Comparison of antitumor effects of multitargeted tyrosine kinase inhibitors in acute myelogenous leukemiaShuiying Hu, Hongmei Niu, Patton Minkin, et al.
Cancer|May 20, 2008
Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosisHiroto Inaba, Ying Fan, Stanley Pounds, et al.
Cancer|April 29, 2021
Association between obesity and neurocognitive function in survivors of childhood acute lymphoblastic leukemia treated only with chemotherapyMayuko Iijima, Wei Liu, John C Panetta, et al.
Cancer|May 31, 2017
Decreased relapsed rate and treatment-related mortality contribute to improved outcomes for pediatric acute myeloid leukemia in successive clinical trialsThomas B Alexander, Lei Wang, Hiroto Inaba, et al.
Blood|November 22, 2019
Predicting success of desensitization after pegaspargase allergyHope D Swanson, John C Panetta, Patricia J Barker, et al.
Cancer|February 27, 2010
Pulmonary dysfunction in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem cell transplantationHiroto Inaba, Jie Yang, Jianmin Pan, et al.
Pharmacotherapy|April 21, 2026
Impact of Dosing Interval Adherence on Pharmacokinetic Outcomes of Recombinant Erwinia Asparaginase in Pediatric Leukemia or LymphomaMilre M Matherne, John C Panetta, Jaclyn Hopp, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 20, 2021
Clinicopathologic and prognostic features of TdT-negative pediatric B-lymphoblastic leukemiaMatthew M Klairmont, Yinmei Zhou, Cheng Cheng, et al.
Pageof 22

Showing results (51-60 of 214) with videos related to

Sort By:
Pageof 22
Haematologica|February 13, 2025
Changes in asparaginase exposure and toxicity profiles in obese pediatric acute lymphoblastic leukemia patientsJohn C Panetta, Emily Ashcraft, Sima Jeha, et al.
Pediatric Blood & Cancer|April 24, 2020
Higher plasma asparaginase activity after intramuscular than intravenous Erwinia asparaginaseJohn C Panetta, Yiwei Liu, Hope D Swanson, et al.
Molecular Cancer Therapeutics|May 17, 2008
Comparison of antitumor effects of multitargeted tyrosine kinase inhibitors in acute myelogenous leukemiaShuiying Hu, Hongmei Niu, Patton Minkin, et al.
Cancer|May 20, 2008
Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosisHiroto Inaba, Ying Fan, Stanley Pounds, et al.
Cancer|April 29, 2021
Association between obesity and neurocognitive function in survivors of childhood acute lymphoblastic leukemia treated only with chemotherapyMayuko Iijima, Wei Liu, John C Panetta, et al.
Cancer|May 31, 2017
Decreased relapsed rate and treatment-related mortality contribute to improved outcomes for pediatric acute myeloid leukemia in successive clinical trialsThomas B Alexander, Lei Wang, Hiroto Inaba, et al.
Blood|November 22, 2019
Predicting success of desensitization after pegaspargase allergyHope D Swanson, John C Panetta, Patricia J Barker, et al.
Cancer|February 27, 2010
Pulmonary dysfunction in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem cell transplantationHiroto Inaba, Jie Yang, Jianmin Pan, et al.
Pharmacotherapy|April 21, 2026
Impact of Dosing Interval Adherence on Pharmacokinetic Outcomes of Recombinant Erwinia Asparaginase in Pediatric Leukemia or LymphomaMilre M Matherne, John C Panetta, Jaclyn Hopp, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 20, 2021
Clinicopathologic and prognostic features of TdT-negative pediatric B-lymphoblastic leukemiaMatthew M Klairmont, Yinmei Zhou, Cheng Cheng, et al.
Pageof 22